- $2.23bn
- $2.12bn
- $197.52m
Annual cashflow statement for Vericel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -9.66 | 2.86 | -7.47 | -16.7 | -3.18 |
Depreciation | |||||
Non-Cash Items | 15.4 | 18.7 | 39.7 | 41.6 | 37.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -14.7 | -6.37 | -6.15 | -11.2 | -3.96 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -7.18 | 17.6 | 29 | 17.7 | 35.3 |
Capital Expenditures | -2.62 | -2.63 | -7.92 | -7.6 | -27.5 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 13.2 | -14.5 | 4.41 | -28.6 | 24.4 |
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 10.6 | -17.2 | -3.5 | -36.2 | -3.13 |
Financing Cash Flow Items | -0.026 | -0.191 | -2.01 | -2.61 | -2.38 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.26 | 6.44 | 9.17 | 1.04 | 3.62 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8.69 | 6.85 | 34.7 | -17.5 | 35.8 |